4831 - 4840 of 8399 Results
Title
Year
-
RESTRICTEDTitle: Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID‐19 ExperienceJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 4Start Page: 361End Page: 372Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12965Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12965Citation Count: 93
-
RESTRICTEDTitle: Medical cannabis as an alternative therapeutics for Parkinsons’ disease: Systematic reviewJournal Name: Complementary Therapies in Clinical PracticePublisher: Elsevier BVVol: 39Issue #:Start Page: 101154End Page: 101154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ctcp.2020.101154Citation Count: 17
-
RESTRICTEDTitle: Neuroimaging the consciousness of self: Review, and conceptual-methodological frameworkJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 112Issue #:Start Page: 164End Page: 212Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neubiorev.2020.01.023Best OA location URL: https://doi.org/10.1016/j.neubiorev.2020.01.023Citation Count: 109
- Oral Sessions2020OPENTitle: Oral SessionsJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: S1Start Page: 1End Page: 102Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.14306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14306Citation Count: 3
-
RESTRICTEDTitle: PINK1 and Parkin: team players in stress-induced mitophagyJournal Name: Biological ChemistryPublisher: Walter de Gruyter GmbHVol: 401Issue #: 6-7Start Page: 891End Page: 899Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/hsz-2020-0135Citation Count: 32
-
RESTRICTEDTitle: Surgical Treatment of Parkinson DiseaseJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 293End Page: 307Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ncl.2020.01.001Best OA location URL: http://manuscript.elsevier.com/S0733861920300013/pdf/S0733861920300013.pdfCitation Count: 13
-
RESTRICTEDTitle: Ten Unsolved Questions About Neuroinflammation in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 16End Page: 24Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28075Best OA location URL: https://inserm.hal.science/inserm-02568209/file/ReviewMDSinflammationRev11%20dgs%20eh.pdfCitation Count: 142
-
RESTRICTEDTitle: Treatment of Nonmotor Symptoms Associated with Parkinson DiseaseJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 269End Page: 292Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2019.12.003Citation Count: 25
-
RESTRICTEDTitle: Treatment of Tardive DyskinesiaJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 379End Page: 396Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2020.01.004Citation Count: 27
- A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's Disease2020RESTRICTEDTitle: A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 7Start Page: 1249End Page: 1253Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28066Citation Count: 39